Skip to main content
Caplight Logo









C the Signs

C the Signs

Private
LondonHealthcare & Life Scienceshttps://www.cthesigns.com/

Last Round

Series B

Jan 29, 2025

Total Funding Raised

$16.23M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

C the Signs is a healthcare technology company that provides an AI-powered clinical decision support platform to identify patients at risk of cancer at the earliest possible stage.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, EHR & EMR, Healthcare Analytics, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportcancer risk assessmentmedical AIEHR integrationelectronic health recordsEHRclinical AIreferral managementpredictive analyticshealthcare SaaSworkflow automationearly cancer detectionhealth techoncology softwaredigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

C the Signs Comparables

Compare C the Signs with similar companies based on industry and business-model similarity.

C the Signs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CancerIQ
82%
Oatmeal Health
69%
Optellum
68%

C the Signs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 29, 2025
AcceleratorFeb 26, 2024
Series AFeb 4, 2022
GrantOct 23, 2018
GrantJul 1, 2017

Key People

Founding team and executive leadership

Miles Payling

Co-Founder And Chief Scientific Officer

Founding Team

Bea Bakshi

Co-Founder CEO

Founding Team

Ken Wu

Chief Technology Officer

Executive Team

C the Signs Investors

Notable investors and investment history

C the Signs investors
InvestorRounds
SBRI HealthcareGrant
Khosla VenturesSeries B
Acequia CapitalSeries A, Series B
AtaraxiaSeries A, Series B
MMC VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 132, 338% of headcount.

  • Jul 13, 2026

    Open roles increased to 123, 315% of headcount.

C the Signs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

C the Signs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about C the Signs's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range39
Year Founded2017
Last FundingJan 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?